GET THE FULL COMPANY
ANALYSIS BUNDLE FOR
Honle Group
Who Owns Honle Group Company?
Understanding the ownership structure of a company like Dr. Hönle AG is crucial for discerning its strategic trajectory, operational influence, and ultimate accountability to stakeholders. Recent shifts in voting rights by significant shareholders, such as Gerlin Participaties Coöperatief U.A. from 4.49% to 2.98% as of December 19, 2024, and Quaero Capital S.A. from 3.19% to 2.99% as of February 12, 2025, highlight the dynamic nature of corporate control and its potential impact on decision-making.
Dr. Hönle AG, a prominent global provider of industrial UV technology, was founded in 1976 and is headquartered in Gilching, Germany. The company's founders envisioned a leader in specialized UV applications, a vision that has propelled it to its current market position across diverse industries including electronics, printing, automotive, and medical technology. As of May 2025, Dr. Hönle AG maintains a market capitalization of approximately €76.99 million and has 6,062,930 shares outstanding, reflecting its status as a publicly traded technology company.
The ownership history of Honle Group AG reveals a landscape shaped by both its founding vision and evolving investor interests. Identifying Honle Group owners requires looking at the current stake ownership and how it has been influenced by institutional investors and public shareholders. This exploration delves into the evolution of its ownership, from its initial founding stakes to the influence of key institutional investors and public shareholders, and how these shifts have shaped the company over time. Understanding Honle Group ownership provides insight into who controls Honle Group and its corporate ownership structure. The company's business ownership details are a key factor for those interested in Honle Group financial ownership and its Honle Group company structure.
The primary shareholders and their respective voting rights are a critical aspect of the Honle Group company structure. While specific majority shareholder details can fluctuate, understanding the Honle Group shareholders is key to grasping the Honle Group parent company's operational direction. The Honle Group leadership is often influenced by the composition of its shareholder base. For instance, the company offers a range of UV curing systems, including the Honle Group BCG Matrix, which are vital for various industrial processes.
As a publicly traded entity, Dr. Hönle AG's ownership is distributed among various investors. The details about Honle Group investors, including institutional and individual shareholders, contribute to the overall Honle Group corporate ownership structure. The company's legal ownership is transparent through its public listing, allowing for a clear view of its stakeholder base. This dynamic ownership environment is essential for anyone seeking to understand the Honle Group business ownership details and the factors influencing its strategic decisions.
Who Founded Honle Group?
Dr. Hönle AG, a company specializing in industrial UV technology, was established in 1976. The founding individuals were Karl Hönle and Günter Schmid. While precise details about their initial equity distribution or the exact number of shares held at the company's inception are not publicly disclosed, their shared objective was to pioneer advancements in industrial UV applications.
The company's early trajectory was marked by a focus on developing UV equipment for industrial use. The first piece of such equipment was created in 1980, followed by its initial application in curing adhesives and plastics within the industry in 1982. This period saw the transition of the partnership, Dr. Hönle, into a private limited company, Dr. K. Hönle GmbH, in 1977.
Information regarding early investors, such as angel investors or friends and family who acquired stakes during the initial phase, is not readily available. Similarly, specific early agreements like vesting schedules or buy-sell clauses are not publicly detailed. There is also no public information available concerning any initial ownership disputes or buyouts that may have occurred.
Karl Hönle and Günter Schmid founded Dr. Hönle AG in 1976. Their aim was to become a leader in industrial UV technology.
The company's initial focus was on creating UV equipment for industrial applications. The first equipment was developed in 1980.
In 1977, the partnership Dr. Hönle was transformed into a private limited company. This entity was named Dr. K. Hönle GmbH.
The company's first industrial application for its UV technology was in 1982. This involved the curing of adhesives and plastics.
Details regarding early backers, angel investors, or friends and family who acquired stakes are not publicly available. Specific early agreements are also not detailed.
There is no public information available that indicates any initial ownership disputes or buyouts within the company's early history.
The foundation of Dr. Hönle AG in 1976 by Karl Hönle and Günter Schmid marked the beginning of a company dedicated to industrial UV technology. The early years were characterized by the development of UV equipment and its application in industrial processes, leading to the company's restructuring into Dr. K. Hönle GmbH in 1977. Understanding the Revenue Streams & Business Model of Honle Group provides further context to the company's growth from its foundational stages.
- Founders: Karl Hönle and Günter Schmid
- Founding Year: 1976
- Company Restructuring: Dr. K. Hönle GmbH in 1977
- First UV Equipment Development: 1980
- First Industrial Application: Curing adhesives and plastics in 1982
- Limited public data on early investors and agreements
Complete Honle Group Strategy Bundle
- 6 Full Frameworks, 1 Company – All Pre-Researched
- Each Framework Fully Sourced with Real Company Data
- Built for Strategy Courses, Case Studies & MBA Programs
- Adapt to Your Assignment – No Starting from Scratch
- 6 Frameworks: SWOT, PESTLE, Porter's, BMC, BCG and 4P's
How Has Honle Group’s Ownership Changed Over Time?
The ownership journey of the company began with its transition to a public entity, marked by an IPO on January 24, 2001, initially listed on the Neuer Markt segment. Prior to this, the company had already established a presence on the stock exchange in 1999. This public offering significantly broadened the potential ownership base, moving beyond private founders or a small group of investors.
As of the first half of the fiscal year 2024/2025, which concluded on March 31, 2025, the company had a total of 6,062,930 shares outstanding. A substantial portion of these, specifically 68.63% (representing 4,161,174 shares), were categorized as free-float, indicating shares readily available for trading by the general public and institutional investors.
| Stakeholder | Percentage of Ownership | Number of Shares | As of Date |
|---|---|---|---|
| Peter Möhrle GmbH & Co. KG | 25.36% | 1,537,450 | September 29, 2024 |
| Lazard Frères Gestion SAS | 4.09% | 248,000 | Late 2024 / Early 2025 |
| Quaero Capital SA | 2.99% | 181,531 | February 6, 2025 |
| Gerlin Participaties Coöperatief U.A. | 2.98% | 180,402 | December 18, 2024 |
| Teslin Capital Management BV | 2.98% | 180,402 | December 18, 2024 |
| Dimensional Fund Advisors LP | 0.82% | 49,515 | June 29, 2025 |
The presence of these institutional investors highlights a diverse ownership structure, which is characteristic of a publicly traded company. Changes in these holdings, such as the noted reductions in voting rights by Quaero Capital S.A. and Gerlin Participaties Coöperatief U.A. in late 2024 and early 2025, can impact stakeholder dynamics and potentially influence decision-making processes. The company operates under a one-share-one-vote principle, meaning each share held grants a single voting right. The management board, in collaboration with the supervisory board, is guiding a strategic realignment observed in late 2024. This involves a focus on core business areas and the discontinuation of unprofitable product lines, all with the objective of achieving sustained strong business performance and a return to high profitability. This strategic direction is aligned with the company's Mission, Vision & Core Values of Honle Group.
The ownership of the company is characterized by a significant free-float percentage and the presence of various institutional investors. Understanding these stakeholders is key to grasping the company's financial landscape.
- The company transitioned to a public entity in 2001.
- A majority of shares are in free-float, available for public trading.
- Key institutional investors hold substantial stakes.
- Ownership shifts can influence company dynamics.
From PESTLE Factors to Full Strategy Bundle
- PESTLE + SWOT + Porter's + BCG + BMC + 4P's in One Bundle
- Every Strategic Angle Covered – Nothing Left to Research
- Pre-filled with Company-Specific Research
- No Missing Sections for Your Case Study
- One Download Covers Your Entire Company Analysis
Who Sits on Honle Group’s Board?
Dr. Hönle AG operates with a dual board structure, a common practice in German corporations, designed to separate management functions from oversight. The Management Board is tasked with the day-to-day operations and strategic direction of the company. As of October 1, 2024, this board comprises two key individuals: Dr. Markus Arendt, who assumed the role of CEO in May 2024, and Robert Stark, serving as Chief Finance Officer. Their leadership guides the company's operational and financial strategies.
The Supervisory Board plays a crucial role in monitoring the Management Board's activities and ensuring the company acts in the best interests of its shareholders. The current members of the Supervisory Board are Dr. Franz Richter, who chairs the board, Dr. Bernhard Gimple, the deputy chairman, and members Niklas Friedrichsen, Prof. Dr. Imke Libon, and Melanie Ott. Notably, Niklas Friedrichsen's position as managing director of the Peter Möhrle Group, an entity holding over 10% of Dr. Hönle AG's shares, highlights a significant connection between a major shareholder and the company's oversight committee.
| Board Member | Role | Affiliation/Notes |
|---|---|---|
| Dr. Markus Arendt | CEO | Management Board |
| Robert Stark | Chief Finance Officer | Management Board |
| Dr. Franz Richter | Chairman | Supervisory Board |
| Dr. Bernhard Gimple | Deputy Chairman | Supervisory Board |
| Niklas Friedrichsen | Member | Supervisory Board; Managing Director of Peter Möhrle Group (indirectly holds >10% of shares) |
| Prof. Dr. Imke Libon | Member | Supervisory Board |
| Melanie Ott | Member | Supervisory Board |
The voting power within Dr. Hönle AG is structured on a straightforward one-share-one-vote principle. This means that each share of the company's stock grants its holder a single vote, ensuring that voting rights are directly proportional to the number of shares owned. Publicly available information does not indicate the existence of any dual-class share structures, special voting rights, golden shares, or founder shares that would allow certain individuals or entities to wield disproportionate control over the company's decisions beyond their equity stake. The company's Growth Strategy of Honle Group is thus influenced by this equitable distribution of voting power among its shareholders.
Dr. Hönle AG's corporate ownership structure is based on a clear, one-share-one-vote system. This ensures that voting power directly correlates with share ownership, promoting a transparent and equitable distribution of influence among its Honle Group shareholders.
- The company is managed by a dual board system: Management Board and Supervisory Board.
- Voting power is directly tied to the number of shares held.
- No special voting rights or dual-class shares are publicly disclosed.
- The Peter Möhrle Group holds a significant stake, exceeding 10%, with a representative on the Supervisory Board.
Honle Group Business Model + Strategy Bundle
- Ideal for Essays, Case Studies & Slides
- Get BCG, SWOT, PESTLE, Porter's, 4P's Mix & BMC Together
- Company-Specific Content Already Organized
- One Bundle Replaces Days of Independent Research
- Buy the Bundle Once. Use Across All Your Assignments
What Recent Changes Have Shaped Honle Group’s Ownership Landscape?
Over the past few years, the ownership of Dr. Hönle AG has seen some adjustments, primarily driven by shifts in institutional investor holdings. While the company has maintained a stable number of outstanding shares, hovering around 6.062 million from 2022 through March 2025, indicating no significant dilution or large-scale buybacks, the landscape of its major stakeholders has experienced minor recalibrations. These changes reflect evolving investment strategies among institutional players in the market.
The share price has experienced a notable decline, with a 41.15% drop from €19.20 on May 16, 2024, to €11.30 as of May 15, 2025. This price movement, alongside operational performance, can influence investor sentiment and, consequently, ownership trends. Understanding who owns Honle Group involves looking at these institutional changes and the company's financial health.
| Shareholder | Stake as of | Voting Rights (%) |
| Peter Möhrle GmbH & Co. KG | September 29, 2024 | 25.36% |
| Gerlin Participaties Coöperatief U.A. | December 19, 2024 | 2.98% |
| Quaero Capital S.A. | February 12, 2025 | 2.99% |
Recent disclosures from late 2024 and early 2025 highlight a reduction in voting rights by some key institutional investors. Gerlin Participaties Coöperatief U.A. decreased its stake from 4.49% to 2.98% by December 19, 2024, and Quaero Capital S.A. similarly reduced its voting rights from 3.19% to 2.99% as of February 12, 2025. In contrast, Peter Möhrle GmbH & Co. KG maintained a significant presence, holding 25.36% of the shares as of September 29, 2024, making it a substantial shareholder in the Honle Group company structure.
The company reported a positive operating result for the 2023/2024 financial year, with sales nearing €98 million. Despite some special effects impacting EBIT, the company forecasts revenue between €95 million and €105 million for the 2024/2025 financial year. Sales for the first half of fiscal year 2024/2025 reached €47.168 million, and the Disinfection Business Unit is expected to see growth due to increasing demand.
Strategic realignments are underway, focusing on core business areas and discontinuing unprofitable product lines. These operational adjustments and the company's focus on growth sectors like disinfection can influence investor sentiment. There are no public announcements regarding planned succession or potential privatization, leaving the long-term corporate ownership structure open to market dynamics.
Identifying Honle Group owners requires monitoring regulatory filings for changes in substantial shareholdings. The current ownership trends suggest a market where institutional investors are actively managing their stakes, with Peter Möhrle GmbH & Co. KG remaining a significant stakeholder. This dynamic is crucial for understanding who controls Honle Group and its overall business ownership details.
The Honle Group financial ownership is characterized by a mix of institutional and potentially private investors. The company's performance, as seen in its sales figures and forecasts, directly impacts its attractiveness to investors. Analyzing these financial details provides insight into the Honle Group's stake ownership and its overall market position, especially when compared to its Competitors Landscape of Honle Group.
From Five Forces to Full Company Analysis
- Includes SWOT, PESTLE, BMC, BCG and 4P's
- Pre-Researched with Company-Specific Data
- Best Value for a Complete Analysis
- Ready to Adapt for Your Case Study
- Ready for Essays and Slidesd
- What is Brief History of Honle Group Company?
- What is Competitive Landscape of Honle Group Company?
- What is Growth Strategy and Future Prospects of Honle Group Company?
- How Does Honle Group Company Work?
- What is Sales and Marketing Strategy of Honle Group Company?
- What are Mission Vision & Core Values of Honle Group Company?
- What is Customer Demographics and Target Market of Honle Group Company?
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.